TY  - GEN
AU  - Kröger,N
AU  - Bornhäuser,M
AU  - Stelljes,M
AU  - Pichlmeier,U
AU  - Trenschel,R
AU  - Schmid,C
AU  - Arnold,R
AU  - Martin,H
AU  - Heinzelmann,M
AU  - Wolschke,C
AU  - Meyer,R G
AU  - Bethge,W
AU  - Kobbe,G
AU  - Ayuk,F
AU  - Gökbuget,N
AU  - Hölzer,D
AU  - Zander,A
AU  - Beelen,D
TI  - Allogeneic stem cell transplantation after conditioning with treosulfan, etoposide and cyclophosphamide for patients with ALL: a phase II-study on behalf of the German Cooperative Transplant Study Group and ALL Study Group (GMALL)
SN  - 1476-5365
PY  - 2016///0912
KW  - Adolescent
KW  - Adult
KW  - Allografts
KW  - Busulfan
KW  - administration & dosage
KW  - Cyclophosphamide
KW  - Etoposide
KW  - Female
KW  - Graft vs Host Disease
KW  - etiology
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Myeloablative Agonists
KW  - Precursor Cell Lymphoblastic Leukemia-Lymphoma
KW  - mortality
KW  - Stem Cell Transplantation
KW  - Transplantation Conditioning
KW  - adverse effects
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/bmt.2015.202
ER  -